Linde E M de Wijs (L E M de Wijs)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

The British journal of dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Clinical and experimental dermatology

Archives of dermatological research

Erasmus University Medical Center

Maastricht University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Erasmus University Medical Center Feb 01 2018

Netherlands

PhD candidate :: Dermatology

Education History

Maastricht University Sep 01 2011 - Jul 01 2017

Netherlands

MSC :: Medicine

Publications

Linde E M de Wijs, Sven van Egmond, Arjan C A Devillers, Tamar E C Nijsten, Dirk-Jan Hijnen, Marjolein Lugtenberg
Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study. Archives of dermatological research (2022)
Linde E M de Wijs, R F T Fujimoto, Eleni-Rosalina Andrinopoulou, Tamar E C Nijsten, Dirk-Jan Hijnen, Yoko Kataoka
Dupilumab treatment in patients with atopic dermatitis: a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures. The British journal of dermatology 185 (3) (2021)
Linde E M de Wijs, José D van der Waa, Tamar E C Nijsten, Jonathan Ian Silverberg, Amalia C M Kunkeler, Dirk-Jan Hijnen
Effects of dupilumab treatment on patch test reactions: A retrospective evaluation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 51 (7) (2021)
Linde E M de Wijs, Jacob Pontoppidan Thyssen, Christian L Vestergaard, Hok Bing Thio, A C M Kunkeler, T Biedermann, Dirk-Jan Hijnen
An approach for the transition from systemic immunosuppressants to dupilumab. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (3) (2020)
Linde E M de Wijs, M M Joustra, Jill Olydam, Tamar E C Nijsten, Dirk-Jan Hijnen
COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (3) (2020)
Linde E M de Wijs, N T Nguyen, A C M Kunkeler, Tamar E C Nijsten, Jeffrey Damman, Dirk-Jan Hijnen
Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series. The British journal of dermatology 183 (4) (2019)
Linde E M de Wijs, J D van der Waa, P H P de Jong, Dirk-Jan Hijnen
Acute arthritis and arthralgia as an adverse drug reaction to dupilumab. Clinical and experimental dermatology 45 (2) (2019)
Linde E M de Wijs, A L Bosma, N S Erler, Loes M Hollestein, Louise A A Gerbens, M A Middelkamp-Hup, A C M Kunkeler, Tamar E C Nijsten, Phyllis I Spuls, Dirk-Jan Hijnen
Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data. The British journal of dermatology 182 (2) (2019)

Linde E M de Wijs.css-eqlu8i{font-size:small;padding-left:4px;} (L E M de Wijs)

Publication Activity (10 Years)

Top Topics

Top Venues

Linde E M de Wijs (L E M de Wijs)